Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Deals
Kangtai Biological Partners with Gennvax Egypt to Commercialize 13-Valent Pneumococcal Vaccine
November 26, 2024
Company
Deals
Haplox and Illumina Mark Milestone with Production of NextSeq 2000Dx-CN-HAP Sequencing System in China
November 1, 2024
Policy / Regulatory
CDE Requests Feedback on 77th Batch of Chemical Generic Reference Preparations by December 20
November 1, 2024
Company
Drug
Kelun-Biotech’s SKB264 NDA Accepted by NMPA for mTNBC, Poised to Be China’s First TROP2-targeted ADC
November 1, 2024
Company
Deals
Nona Biosciences Partners with Evive Biotech to Discover H2L2 Antibodies Using Harbour Mice Platform
November 1, 2024
Company
Drug
Chinese Biotech Precision Biotechnology Gets NMPA Green Light for Advanced Cancer Therapies
November 1, 2024
Company
Deals
Bayer Partners with Salus Optima to Advance Precision Health Solutions for Healthy Aging
November 1, 2024
Company
Drug
MSD Halts Phase III Trial of Keytruda Combo in NSCLC After Missing Primary Endpoints
December 10, 2024
Company
Drug
Novartis Reports Kisqali Success in Reducing Recurrence Risk in Early Breast Cancer
November 2, 2024
Company
Fosun Pharma to Establish Greater Bay Area HQ in Shenzhen’s Pingshan District
November 1, 2024
Company
Drug
Keymed Biosciences’ Stapokibart Filing Accepted for Priority Review in China for Atopic Dermatitis
November 2, 2024
Company
Deals
Zelgen Biopharmaceuticals Partners with Grand Life Sciences for Exclusive Marketing of Recombinant Human Thrombin
November 1, 2024
1
2
…
13
14
15
16
17
…
21
22
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?